Skip to content
★ Sign in to follow
JE

James Edward Smith Jr.

Shareholder
Pernix Therapeutics Holdings, Inc.
Total declarations
62
Company
1
▲ Purchases (0 ops.)
—
▼ Sales (57 ops.)
€7.1M

Latest filing published 21 May 2014 for PERNIX THERAPEUTICS HOLDINGS, INC., €537k.

Insider track record

Disclosed buys
0
Disclosed sells
57
Signal history

No signal scores available.

James Edward Smith Jr.: trading record in brief

James Edward Smith Jr. discloses dealings in Pernix Therapeutics Holdings, Inc. to SEC (Form 4). In total, 62 filings cover trades dated from 9 March 2010 to 21 May 2014.

Sales make up the whole of the open-market record (57 sales, €7.1M). Besides market trades, the filings include 5 share grants. 2014 to date brings no purchases and 56 sales.

On 21 May 2014 came the latest disclosure, an open-market sale for €537k in Pernix Therapeutics Holdings, Inc. Between a trade and the moment it shows up on SEC (Form 4), the median delay is 2 days. For comparison, the SEC allows two business days to file a Form 4. Sales are harder to read than purchases, since they often meet personal needs such as tax or diversification. This summary is built from SEC (Form 4) disclosures alone and does not predict where the share price will go.

Companies and markets linked to James Edward Smith Jr.

Open company profiles for insider transactions, fundamentals and analyst consensus when available.

Declarations62 total

25 of 62 declarations